成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Struktur
2626934-45-8
CAS-Nr.
2626934-45-8
Englisch Name:
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-
Synonyma:
Mansonone G;Avatrapa impurity 1;Avatroposide impurities6;Avatrombopag Impurity 17 HCl;3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-;5-chloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-6-(dimethylamino)pyridine-3-carboxamide;5-Chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide (Avatrombopag Impurity)
CBNumber:
CB38993787
Summenformel:
C25H30Cl2N6OS2
Molgewicht:
565.58
MOL-Datei:
2626934-45-8.mol

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Eigenschaften

Dichte
1.398±0.06 g/cm3(Predicted)
pka
4.49±0.70(Predicted)

Sicherheit

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 24)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11922 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+8618627948422
 sale@hdimpurity.com China 3389 58
Guangzhou CATO Research Chemicals Inc. 		+86-020-81960175-617 +8615602392859
 Intermediate@cato-chem.com China 8322 58
Moxin Chemicals 		+8617320513646
 mike@molcoo.com China 9511 58
QUALITY CONTROL SOLUTIONS LTD. 		0755-66853366; 13670046396
 ORDERS@QCSRM.COM China 24342 58
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
 sales@bjcomparison.com China 4719 58
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
 2880679888@qq.com China 2967 58
Shenzhen Botel Biotechnology Co. Ltd. 0755-22202135 13316968096
 1979313431@qq.com China 9033 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 020-36607679 17825480238
 3008233746@qq.com China 9919 12
Shanghai Xinlitai Pharmaceutical Co. , Ltd. 18616665298
 wenjie.li@bocimed.com China 234 58
  • 3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-
  • Avatrombopag Impurity 17 HCl
  • 5-chloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-6-(dimethylamino)pyridine-3-carboxamide
  • Avatroposide impurities6
  • Avatrapa impurity 1
  • Mansonone G
  • 5-Chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide (Avatrombopag Impurity)
  • 2626934-45-8
  • C25H30Cl2N6OS2
Copyright 2019 ? ChemicalBook. All rights reserved